These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11342625)

  • 1. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ.
    Radoja S; Saio M; Frey AB
    J Immunol; 2001 May; 166(10):6074-83. PubMed ID: 11342625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.
    Zaks TZ; Chappell DB; Rosenberg SA; Restifo NP
    J Immunol; 1999 Mar; 162(6):3273-9. PubMed ID: 10092779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.
    Koneru M; Schaer D; Monu N; Ayala A; Frey AB
    J Immunol; 2005 Feb; 174(4):1830-40. PubMed ID: 15699109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
    Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
    J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
    Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
    J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.
    Berhanu A; Huang J; Watkins SC; Okada H; Storkus WJ
    J Immunol; 2007 Mar; 178(6):3400-8. PubMed ID: 17339434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.
    Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ
    J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
    Tamakawa N; Saio M; Suwa T; Ohe N; Yoshimura S; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver damage by infiltrating CD8+ T cells is Fas dependent.
    Kennedy NJ; Russell JQ; Michail N; Budd RC
    J Immunol; 2001 Dec; 167(11):6654-62. PubMed ID: 11714837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
    Hishii M; Kurnick JT; Ramirez-Montagut T; Pandolfi F
    Clin Exp Immunol; 1999 Jun; 116(3):388-94. PubMed ID: 10361224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2.
    Wigginton JM; Lee JK; Wiltrout TA; Alvord WG; Hixon JA; Subleski J; Back TC; Wiltrout RH
    J Immunol; 2002 Oct; 169(8):4467-74. PubMed ID: 12370382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.
    Wigginton JM; Gruys E; Geiselhart L; Subleski J; Komschlies KL; Park JW; Wiltrout TA; Nagashima K; Back TC; Wiltrout RH
    J Clin Invest; 2001 Jul; 108(1):51-62. PubMed ID: 11435457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.
    Saio M; Radoja S; Marino M; Frey AB
    J Immunol; 2001 Nov; 167(10):5583-93. PubMed ID: 11698429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
    Teh HS; Seebaran A; Teh SJ
    J Immunol; 2000 Nov; 165(9):4814-21. PubMed ID: 11046004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC
    Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
    Evans R; Kamdar SJ; Duffy T; Edison L
    J Immunol; 1993 Jan; 150(1):177-84. PubMed ID: 8417123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.